Allicin ameliorates imiquimod‐induced psoriasis‐like skin inflammation via disturbing the interaction of keratinocytes with IL‐17A
British Journal of Pharmacology · 2023-03 · 180 (5) · 628-646
DOI: 10.1111/bph.15983 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 30.11.2022. Verfasst von Lu Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Xinjiang Medical University, Urumqi, China. Hauptthemen laut MEDLINE: Psoriasis, Dermatitis. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science Fund for Distinguished Young Scholars of Xinjiang Uygur Autonomous Region, Natural Science Foundation of Xinjiang Uygur Autonomous Region, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Background and Purpose Psoriasis is an inflammatory skin disease of chronic recurrence mediated by the interaction between IL‐17 and keratinocytes, which sustains a vicious circle of inflammation. Safe and effective natural medicine is a potential strategy for the clinical treatment of psoriasis. Given its prominent anti‐proliferative and anti‐inflammatory properties, we investigated the actions of allicin in improving psoriasis. Experimental Approach Pharmacodynamic studies were carried out in mice after topical administration of allicin against psoriasis‐like lesions induced by imiquimod. Skin sensitization tests were evaluated on guinea pigs. Toxicological studies and skin irritation tests were assessed by consecutive topical allicin alone on the skin of rabbits. RNA‐seq probed transcriptomic changes following allicin. Western blot explored the actions of allicin on the interaction between IL‐17A and keratinocytes. Changes in inflammatory factor expression were analysed by qPCR and immunohistochemistry. Key Results Allicin significantly improved the epidermal structure by inhibiting the excessive proliferation and reduced apoptosis of keratinocytes. Furthermore, allicin reduced the secretion of inflammatory cytokines (IL‐17A/F, IL‐22, IL‐12, and IL‐20), chemokines (CXCL2, CXCL5, and CCL20), and anti‐bacterial peptides (S100a8/9). Mechanistically, allicin directly inhibited the IL‐17‐induced TRAF6/MAPK/NF‐κB and STAT3/NF‐κB signalling cascades in keratinocytes, thus breaking the positive inflammatory feedback and alleviating imiquimod‐induced psoriasis‐like dermatitis in mice. Importantly, topical administration of allicin did not cause skin allergy, and the safety and adaptability of long‐term application were verified. Conclusions and Implications Interfering with IL‐17 signalling in keratinocytes with allicin is a promising strategy for treating psoriasis, given its safety and effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Xinjiang Medical University, Urumqi, China.
- Key Laboratory of Garlic Medicinal Research in Xinjiang, Urumqi, China.
- Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
- Xinjiang University of Science and Technology, Korla, China.
ORCID-Profile: Jingjing Duan, Jianguang Li
Förderung
- Science Fund for Distinguished Young Scholars of Xinjiang Uygur Autonomous Region
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
- Fundamental Research Funds for the Central Universities
- Science Fund for Distinguished Young Scholars of Xinjiang Autonomous Region
- Natural Science Foundation of Xinjiang
Zitieren
APA
Zhang, L., Ma, X., Shi, R., Zhang, L., Zhao, R., Duan, R., Qin, Y., Gao, S., Li, X., Duan, J., & Li, J. (2023). Allicin ameliorates imiquimod‐induced psoriasis‐like skin inflammation via disturbing the interaction of keratinocytes with IL‐17A. British Journal of Pharmacology, 180(5), 628-646. https://doi.org/10.1111/bph.15983
Vancouver
Zhang L, Ma X, Shi R, Zhang L, Zhao R, Duan R, et al. Allicin ameliorates imiquimod‐induced psoriasis‐like skin inflammation via disturbing the interaction of keratinocytes with IL‐17A. British Journal of Pharmacology. 2023;180(5):628-646. doi:10.1111/bph.15983
BibTeX
@article{Zhang2023,
author = {Zhang, Lu and Ma, Xuehong and Shi, Rongmei and Zhang, Libo and Zhao, Ruolin and Duan, Ran and Qin, Yuanyuan and Gao, Sijia and Li, Xinxia and Duan, Jingjing and Li, Jianguang},
title = {Allicin ameliorates imiquimod‐induced psoriasis‐like skin inflammation via disturbing the interaction of keratinocytes with IL‐17A},
journal = {British Journal of Pharmacology},
year = {2023},
volume = {180},
number = {5},
pages = {628--646},
doi = {10.1111/bph.15983}
}
EUVIMED